Hemispherx Biopharma Inc (NYSE American:HEB)

0.3331
Delayed Data
As of Apr 23
 -0.0219 / -6.17%
Today’s Change
0.30
Today|||52-Week Range
0.84
-3.73%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Hemispherx Biopharma Inc have a median target of 17.40, with a high estimate of 17.40 and a low estimate of 17.40. The median estimate represents a +5,123.66% increase from the last price of 0.33.

Analyst Recommendations

There are no recommendations available.

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
--
Sales
-$32.8B
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually 65,548.35%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.